Penn researchers invent microrobots to brush teeth
In a proof-of-concept study, a robotic microswarm of nanoparticles, arranged in bristle-like structures, effectively cleaned plaque and decay-causing bacteria from both mock and human teeth.
Press Highlights of FY22
During the 2022 fiscal year, there were 98 press mentions for PCI programs, startups and partners. Some of the most popular and widely circulated stories are included here.
Peroxitech raises $25M Series A
PCIV startup Peroxitech Inc. announced the successful completion of a $25M Series A financing for treatment of acute lung injury (ALI) into clinical development.
Penn Engineering Lab develops next-generation drug delivery technologies
Mike Mitchell's lab has numerous ongoing research partnerships to support new therapeutic solutions with commercial entities that were facilitated by PCI.
Philadelphia Cell and Gene Therapy Jobs More Than Doubled in Less Than Three Years
As the number of gene and cell therapy jobs continue to grow, Philadelphia continues to attract diverse pools of talent.
Penn spinout Verismo Therapeutics Makes Agreement to Fund University Research of KIR-CAR platform of Car-T to Target Solid Tumors
Learn about Penn spinout Verismo Therapeutics' agreement to fund four years of university research of KIR-CAR platform of Car-T to target solid tumors.
Pharma Companies Search for Solutions in the Face of Upcoming Patent Cliff
Read about the current state of the biopharma industry in the face of pending patent cliff.
Carisma Therapeutics continues to thrive and expand
Penn and Carisma Therapeutics (Carisma) have strengthened the intellectual property portfolio covering this technology with the issuance of five additional patents in 2022.
Staff Spotlight: Meet PCI’s Newest Team Members
Meet PCI's newest staff members and read their bios.
The Future of Research-Based Innovation Hubs with the Rise of Remote Work
John Swartley and Bhavana Mohanraj discuss how working remotely will impact research and innovation hubs.